Cannapharmarx Inc (CPMD)
0.01
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Cannapharmarx Max Drawdown (5Y): 99.98% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 99.98% |
| March 31, 2024 | 99.98% |
| February 29, 2024 | 99.98% |
| January 31, 2024 | 99.97% |
| December 31, 2023 | 99.97% |
| November 30, 2023 | 99.94% |
| October 31, 2023 | 99.79% |
| September 30, 2023 | 99.78% |
| August 31, 2023 | 99.78% |
| July 31, 2023 | 99.78% |
| June 30, 2023 | 99.78% |
| May 31, 2023 | 99.76% |
| April 30, 2023 | 99.76% |
| March 31, 2023 | 99.76% |
| February 28, 2023 | 99.76% |
| January 31, 2023 | 99.76% |
| December 31, 2022 | 99.76% |
| November 30, 2022 | 99.76% |
| October 31, 2022 | 99.72% |
| September 30, 2022 | 99.72% |
| August 31, 2022 | 99.68% |
| July 31, 2022 | 99.68% |
| June 30, 2022 | 99.68% |
| May 31, 2022 | 99.67% |
| April 30, 2022 | 99.65% |
| Date | Value |
|---|---|
| March 31, 2022 | 99.64% |
| February 28, 2022 | 99.64% |
| January 31, 2022 | 99.64% |
| December 31, 2021 | 99.64% |
| November 30, 2021 | 99.39% |
| October 31, 2021 | 99.39% |
| September 30, 2021 | 99.28% |
| August 31, 2021 | 99.17% |
| July 31, 2021 | 99.05% |
| June 30, 2021 | 99.05% |
| May 31, 2021 | 99.05% |
| April 30, 2021 | 99.05% |
| March 31, 2021 | 99.05% |
| February 28, 2021 | 99.05% |
| January 31, 2021 | 99.05% |
| December 31, 2020 | 99.05% |
| November 30, 2020 | 99.05% |
| October 31, 2020 | 99.05% |
| September 30, 2020 | 99.05% |
| August 31, 2020 | 99.05% |
| July 31, 2020 | 99.05% |
| June 30, 2020 | 99.05% |
| May 31, 2020 | 99.05% |
| April 30, 2020 | 99.05% |
| March 31, 2020 | 96.99% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
96.99%
Minimum
May 2019
99.98%
Maximum
Feb 2024
99.04%
Average
99.39%
Median
Oct 2021
Max Drawdown (5Y) Benchmarks
| Acasti Pharma Inc | 98.73% |
| Aurinia Pharmaceuticals Inc | 87.58% |
| Edesa Biotech Inc | 99.58% |
| Lexaria Bioscience Corp | 98.90% |
| Xenon Pharmaceuticals Inc | 64.74% |